Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02658890
Title An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | NOR | ITA | FRA | FIN | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
Local Institution - 0028 Tucson Arizona 85724-5024 United States Details
Local Institution - 0026 La Jolla California 92093-0698 United States Details
Local Institution - 0035 Tampa Florida 33612-9497 United States Details
Local Institution - 0005 Atlanta Georgia 30322 United States Details
Local Institution - 0048 Atlanta Georgia 30342 United States Details
Local Institution - 0027 Chicago Illinois 60637 United States Details
Local Institution - 0051 Lutherville Maryland 21093 United States Details
Local Institution - 0049 Detroit Michigan 48201 United States Details
Local Institution - 0006 Saint Louis Missouri 63110 United States Details
Local Institution - 0033 Hackensack New Jersey 07601 United States Details
Local Institution - 0041 New York New York 10016 United States Details
Local Institution - 0030 Cleveland Ohio 44195 United States Details
Local Institution - 0034 Philadelphia Pennsylvania 19111-2412 United States Details
Local Institution - 0057 Pittsburgh Pennsylvania 15232 United States Details
Local Institution - 0043 Nashville Tennessee 37232 United States Details
Local Institution - 0045 North Sydney New South Wales 2146 Australia Details
Local Institution - 0029 Sydney New South Wales 2010 Australia Details
Local Institution - 0046 Westmead New South Wales 2145 Australia Details
Local Institution - 0044 Brisbane Queensland 4102 Australia Details
Local Institution - 0008 Clayton Victoria 3168 Australia Details
Local Institution - 0004 Melbourne Victoria 3000 Australia Details
Local Institution - 0047 Nedlands Western Australia 6009 Australia Details
Local Institution - 0003 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0002 Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution - 0001 Toronto Ontario M5G 1Z5 Canada Details
Local Institution Greenfield Park Quebec J4V 2H1 Canada Details
Local Institution - 0036 Montreal Quebec H3T 1E2 Canada Details
Local Institution - 0059 Helsinki 00180 Finland Details
Local Institution - 0040 Lille CEDEX 59037 France Details
Local Institution - 0024 Lyon Cedex 08 69373 France Details
Local Institution - 0053 Marseille Cedex 5 13385 France Details
Local Institution - 0052 Nantes Cedex 01 44093 France Details
Local Institution - 0025 Paris 75005 France Details
Local Institution - 0023 Toulouse 31100 France Details
Local Institution - 0022 Villejuif 94800 France Details
Local Institution - 0019 Essen 45147 Germany Details
Local Institution - 0013 Heilbronn 74078 Germany Details
Local Institution - 0010 Milano 20132 Italy Details
Local Institution - 0011 Milano 20133 Italy Details
Local Institution - 0012 Milano 20141 Italy Details
Local Institution - 0009 Rozzano MI 20089 Italy Details
Local Institution - 0054 Oslo 0424 Norway Details
Local Institution - 0042 Warszawa Mazowieckie 02-781 Poland Details
Local Institution - 0017 Barcelona 08035 Spain Details
Local Institution - 0016 Madrid 28040 Spain Details
Local Institution - 0018 Madrid 28050 Spain Details
Local Institution - 0055 Solna 171 64 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field